|
|
Therapeutic disruption of Connexin43-mediated microtubule regulation to target glioblastoma cancer stem cells
|
1R41CA217503-01
|
$224,999
|
$224,999
|
LAMOUILLE, SAMY
|
ACOMHAL RESEARCH, INC.
|
|
|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
5R42CA153845-03
|
$772,615
|
$772,615
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
1R01CA219667-01
|
$554,770
|
$554,770
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
5K01CA190235-03
|
$140,400
|
$140,400
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy
|
1R01CA221197-01
|
$633,169
|
$633,169
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-04
|
$577,030
|
$577,030
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
1F32CA221015-01
|
$56,694
|
$56,694
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-04
|
$318,923
|
$318,923
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
|
5U01CA199288-03
|
$578,693
|
$578,693
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
1R01CA215452-01
|
$362,569
|
$181,285
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-01S1
|
$14,309
|
$7,155
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$13,017
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$13,076
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$13,448
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$27,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$357,843
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
2R01CA155769-06A1
|
$410,877
|
$410,877
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-03
|
$1
|
$1
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$1,466
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$2,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
5R01CA185137-04
|
$882,372
|
$882,372
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Epigenetic regulation of cellular plasticity and cancer cell fate
|
1R35CA210104-01A1
|
$753,725
|
$376,863
|
SHI, YANG
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$52,212
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$278,628
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
|
5R01CA166172-05
|
$368,313
|
$368,313
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-03
|
$377,464
|
$377,464
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
5R01CA176203-04
|
$343,900
|
$343,900
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
3U24CA180918-05S1
|
$254,713
|
$84,055
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-05
|
$668,865
|
$220,725
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
5P01CA174645-05
|
$1,209,609
|
$810,438
|
MCDANNOLD, NATHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Open source diffusion MRI technology for brain cancer research
|
5U01CA199459-03
|
$368,313
|
$368,313
|
O'DONNELL, LAUREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
In vivo imaging of encapsulated stem cells in mouse models of tumor resection
|
7R01CA173077-05
|
$334,659
|
$334,659
|
SHAH, KHALID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
In vivo imaging of the stem cell loaded oncolytic viruses for cancer therapy
|
7R01CA204720-02
|
$406,031
|
$406,031
|
SHAH, KHALID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
|
1R01CA219943-01
|
$502,615
|
$502,615
|
BEROUKHIM, RAMEEN
|
BROAD INSTITUTE, INC.
|
|
|
Center of Excellence for High Throughput Proteogenomic Characterization
|
5U24CA210986-02
|
$1,288,045
|
$425,055
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
|
Steady states and cellular transitions associated with carcinogenesis and tumor progression
|
1U01CA217655-01
|
$644,276
|
$322,138
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-03
|
$2,403,338
|
$1,754,437
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
Simultaneous Detection of Proteins and Whole Transcriptomes in Single Cells
|
1F32CA213966-01
|
$56,694
|
$56,694
|
XU, ALEXANDER
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
DECONVOLUTION OF CLONAL HETEROGENEITY FROM BULK AND SINGLE-CELL VARIATION DATA
|
1R21CA216452-01
|
$187,064
|
$187,064
|
SCHWARTZ, RUSSELL
|
CARNEGIE-MELLON UNIVERSITY
|
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
5R01CA187780-03
|
$385,491
|
$385,491
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
|
1R01CA217956-01
|
$662,909
|
$662,909
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions
|
5F31CA196265-03
|
$49,044
|
$49,044
|
DORAND, RODNEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
$17,831
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
$9,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
$30,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
$21,873
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
$734,327
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-03
|
$617,516
|
$617,516
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
$3,825
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Total relevant funding to Brain for this search: $216,979,499
|
